8. Immunological Aspects Of The Cytomegalovirus Infections After Pediatric Liver Transplantation

Authors

  • N.Zh. Yerimova «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan
  • B.K. Shirtaev «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan
  • B.B. Baimakhanov «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan
  • A.T. Chormanov «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan
  • М.М. Sundetov «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan
  • D.R. Kurbanov «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan
  • K.U. Khalykov «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan
  • D. A. Kokimbayev «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan
  • B.A. Alkhanov «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan

Downloads

Abstract

CMV infection is one of the most common infectious complications of viral etiology among both adult patients and children after liver transplantation. Our experience shows that the appointment of preventive therapy led to a decrease in the frequency of indirect effects of CMVI, and also improved the survival rates of patients after transplantation. This article describes in detail the immunological changes in the background of CMV infection and immunosuppression.

Keywords

Cytomegalovirus, immunosuppression, antibodies, valganciclovir

Published

2021-08-20

Issue

No. 2 (2021)

Section

Статьи